Page last updated: 2024-11-03

primidone and Craniofacial Dysarthrosis

primidone has been researched along with Craniofacial Dysarthrosis in 2 studies

Primidone: A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite.
primidone : A pyrimidone that is dihydropyrimidine-4,6(1H,5H)-dione substituted by an ethyl and a phenyl group at position 5. It is used as an anticonvulsant for treatment of various types of seizures.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koch, S1
Göpfert-Geyer, I1
Jäger-Roman, E1
Jakob, S1
Huth, H1
Hartmann, A1
Rating, D1
Helge, H1
Myhre, SA1
Williams, R1

Trials

1 trial available for primidone and Craniofacial Dysarthrosis

ArticleYear
[Anti-epileptic agents during pregnancy. A prospective study on the course of pregnancy, malformations and child development].
    Deutsche medizinische Wochenschrift (1946), 1983, Feb-18, Volume: 108, Issue:7

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Akathisia, Drug-Induced; Anencephaly; Ant

1983

Other Studies

1 other study available for primidone and Craniofacial Dysarthrosis

ArticleYear
Teratogenic effects associated with maternal primidone therapy.
    The Journal of pediatrics, 1981, Volume: 99, Issue:1

    Topics: Abnormalities, Drug-Induced; Child; Child Development; Child, Preschool; Craniofacial Dysostosis; Ep

1981